Nazione: Australia
Lingua: inglese
Fonte: Department of Health (Therapeutic Goods Administration)
Milnacipran hydrochloride
Pierre Fabre Medicament Australia Pty Ltd
Medicine Registered
CONSUMER MEDICINE INFORMATION Version: A01-1111 1 Supercedes: NIL JONCIA ® 25, 50, 100 MG CAPSULES _Milnacipran hydrochloride _ _ _ _ _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Joncia ® . It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking Joncia ® against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT JONCIA ® IS USED FOR Joncia ® is used to manage fibromyalgia. Fibromyalgia is a health problem involving muscle and joint pain, tenderness, tiredness, sleep problems and a number of symptoms such as morning stiffness, mood disturbances and cognition problems. Joncia ® is a kind of medicine called a serotonin-noradrenaline reuptake inhibitor which has the ability to increase the levels of the biochemicals, serotonin and noradrenaline thereby improving the problems experienced with fibromyalgia syndrome. Your doctor may have prescribed Joncia ® for another purpose. Ask your doctor if you have any questions about why Joncia ® has been prescribed for you. This medicine is available only on a doctor’s prescription. BEFORE YOU TAKE JONCIA ® _WHEN YOU MUST NOT _ _TAKE IT _ YOU MUST NOT TAKE JONCIA ® IF YOU ARE TAKING MEDICINE TO TREAT DEPRESSION. Joncia ® is not used to treat depression, but it acts like medicines that are used to treat depression (antidepressants) and other Leggi il documento completo
Version: A01-041111 Page 1 of 19 Supercedes: NIL PRODUCT INFORMATION JONCIA ® 25, 50, 100 MG CAPSULES NAME OF THE MEDICINE milnacipran hydrochloride (1RS, 2SR)-2-(aminomethyl)-_N,N_-diethyl-1-phenylcyclopropane-1-carboxamide hydrochloride (IUPAC name) CAS number: 101152-94-7 DESCRIPTION Milnacipran hydrochloride is a white to almost white crystalline powder with the molecular formula C 15 H 23 ClN 2 O and a molecular weight of 282.8. Milnacipran hydrochloride is freely soluble in water, methanol, ethanol, butanol, chloroform, dichloromethane and very slightly soluble in ethyl ether. It is non to slightly hygroscopic with a pKa value of 9.65. Milnacipran hydrochloride is a racemic mixture of the isomers 1R, 2S and 1S, 2R. The partition coefficient between octanol and an aqueous buffer (pH = 7.2), P=0.27 shows the highly hydrophilic character of milnacipran hydrochloride. The milnacipran hydrochloride drug product is presented in an immediate-release hard capsule containing 25, 50 and 100 mg of milnacipran hydrochloride. Milnacipran hydrochloride capsules also contain the excipients: calcium hydrogen phosphate, carmellose calcium, povidone K30, silica hydrophobic colloidal, magnesium stearate and talc-purified. The hard capsule shells for the 25 mg and 100 mg strengths contain titanium dioxide (E171), quinoline yellow (E104), sunset yellow FCF (E110) and gelatin. The hard capsule shell for the 50 mg strength contains titanium dioxide (E171), sunset yellow FCF (E110) and gelatin. The capsules are marked with food grade ink. Version: A01-041111 Page 2 of 19 Supercedes: NIL PHARMACOLOGY PHARMACODYNAMICS Milnacipran is a balanced, specific, dual reuptake inhibitor of noradrenaline (NA) and serotonin (5-hydroxytryptamine [5 HT]) Leggi il documento completo